WaferGen Bio systems Insiders

WaferGen Bio-systems employs about 55 people. The company is managed by 8 executives with a total tenure of roughly 95 years, averaging almost 11.0 years of service per executive, having 6.88 employees per reported executive. Breaking down WaferGen Bio-systems' management performance can provide insight into the firm performance.
Rolland Carlson  CEO
CEO and President and Director
Ivan Trifunovich  Chairman
Executive Chairman
  
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

WaferGen Bio-systems Management Team Effectiveness

The company has return on total asset (ROA) of (90.11) % which means that it has lost $90.11 on every $100 spent on assets. This is way below average. WaferGen Bio-systems' management efficiency ratios could be used to measure how well WaferGen Bio-systems manages its routine affairs as well as how well it operates its assets and liabilities.
The company has Profit Margin (PM) of (175.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (171.93) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $171.93.

WaferGen Bio-systems Notable Stakeholders

A WaferGen Bio-systems stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as WaferGen Bio-systems often face trade-offs trying to please all of them. WaferGen Bio-systems' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting WaferGen Bio-systems' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Rolland CarlsonCEO and President and DirectorProfile
Ivan TrifunovichExecutive ChairmanProfile
Michael HenighanCFO, Secretary and TreasurerProfile
Makoto KaneshiroIndependent DirectorProfile
Robert SchuerenDirectorProfile
Joel KanterLead Independent DirectorProfile
William McKenzieDirectorProfile
Raymond HautamakiIndependent DirectorProfile

WaferGen Bio-systems Workforce Analysis

Traditionally, organizations such as WaferGen Bio-systems use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare WaferGen Bio-systems within its industry.

WaferGen Bio-systems Manpower Efficiency

Return on WaferGen Bio-systems Manpower

Revenue Per Employee168K
Revenue Per Executive1.2M
Net Loss Per Employee379.1K
Net Loss Per Executive2.6M
Working Capital Per Employee70.9K
Working Capital Per Executive487.6K
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the WaferGen Bio-systems information on this page should be used as a complementary analysis to other WaferGen Bio-systems' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in WaferGen Stock

If you are still planning to invest in WaferGen Bio-systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the WaferGen Bio-systems' history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency